Company intelligence / Profile preview
Regeneration Biomedical, Inc.
Newport Beach, California, United Statesregenerationbiomedical.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Phase 1 clinical trial data on the first cohort of Alzheimer's patients showed RB-ADSCs were well tolerated, reduced levels of p-Tau and amyloid-beta at 12 weeks, and improved Mini-Mental State Examination (MMSE) scores in two of three subjects[7]
- Therapeutic areas
- Neurology
- Modalities
- Autologous stem cell therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Regeneration Biomedical, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Regeneration Biomedical, Inc..